<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">32886203</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-1084</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>European radiology</Title><ISOAbbreviation>Eur Radiol</ISOAbbreviation></Journal><ArticleTitle>A susceptibility-weighted imaging qualitative score of the motor cortex may be a useful tool for distinguishing clinical phenotypes in amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1281</StartPage><EndPage>1289</EndPage><MedlinePgn>1281-1289</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00330-020-07239-0</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To distinguish amyotrophic lateral sclerosis (ALS) and its subtypes from ALS mimics and healthy controls based on the assessment of iron-related hypointensity of the primary motor cortex in susceptibility-weighted imaging (SWI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We enrolled 64 patients who had undergone magnetic resonance imaging studies with clinical suspicions of ALS. The ALS group included 48 patients; the ALS-mimicking disorder group had 16 patients. The ALS group was divided into three subgroups according to the prevalence of upper motor neuron (UMN) or lower motor neuron (LMN) impairment, with 12 subjects in the UMN-predominant ALS group (UMN-ALS), 16 in the LMN-predominant ALS group (LMN-ALS), and 20 with no prevalent impairment (C-ALS). The Motor Cortex Susceptibility (MCS) score was defined according to the hypointensity of the primary motor cortex in the SWI sequence. Its diagnostic accuracy in differentiating groups was evaluated.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The MCS was higher in the ALS group than in the healthy control and ALS-mimicking disorder groups (p&#xa0;&lt;&#x2009;0.001). Among ALS subgroups, the MCS was significantly higher in the UMN-ALS group than in the healthy control (p&#xa0;&lt;&#x2009;0.001), ALS-mimicking disorder (p&#xa0;=&#x2009;0.002), and LMN-ALS groups (p&#xa0;=&#x2009;0.002) and higher in the C-ALS group than in the healthy control group (p&#xa0;=&#x2009;0.019). An MCS value &#x2265;&#x2009;2 showed specificity and a positive predictive value of 100% in the detection of both UMN-ALS and C-ALS patients.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The assessment of MCS in the SWI sequence could be a useful tool in supporting diagnosis in patients suspicious for ALS with prevalent signs of UMN impairment or with no prevalence signs of UMN or LMN impairment.</AbstractText><AbstractText Label="KEY POINTS" NlmCategory="CONCLUSIONS">&#x2022; The hypointensity of the primary motor cortex in susceptibility-weighted imaging could support the diagnosis of ALS. &#x2022; Our new qualitative score called MCS shows high specificity and positive predictive value in differentiating ALS patients with upper motor neuron impairment from patients with ALS-mimicking disorders and healthy controls.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Conte</LastName><ForeName>Giorgio</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-1562-7389</Identifier><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sbaraini</LastName><ForeName>Sara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-2509-9345</Identifier><AffiliationInfo><Affiliation>Neuroradiology Unit, Department of Radiology, ASST Santi Paolo e Carlo, San Carlo Borromeo Hospital, via Pio II n. 3, Milan, Italy. sara.sbaraini@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morelli</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-4027-958X</Identifier><AffiliationInfo><Affiliation>Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano IRCCS, piazzale Brescia 20, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Casale</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caschera</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Contarino</LastName><ForeName>Valeria Elisa</ForeName><Initials>VE</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scola</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cinnante</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trogu</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano IRCCS, piazzale Brescia 20, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Universit&#xe0; degli Studi di Milano, via Festa del Perdono 7, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triulzi</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, via Francesco Sforza 35, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Universit&#xe0; degli Studi di Milano, via Festa del Perdono 7, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silani</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-7698-3854</Identifier><AffiliationInfo><Affiliation>Department of Neurology-Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano IRCCS, piazzale Brescia 20, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pathophysiology and Transplantation, Universit&#xe0; degli Studi di Milano, via Festa del Perdono 7, Milan, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Radiol</MedlineTA><NlmUniqueID>9114774</NlmUniqueID><ISSNLinking>0938-7994</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Eur Radiol. 2020 Nov 27;:</RefSource><PMID Version="1">33245496</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Motor neuron disease</Keyword><Keyword MajorTopicYN="N">Primary motor cortex</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>3</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32886203</ArticleId><ArticleId IdType="doi">10.1007/s00330-020-07239-0</ArticleId><ArticleId IdType="pii">10.1007/s00330-020-07239-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lodoloh A, Drory V, Hardiman O et al (2015) A revision of the El Escorial criteria &#x2013; 2015. Amyotroph Lateral Scler frontotemporal Degener 16(5&#x2013;6):291&#x2013;292</Citation></Reference><Reference><Citation>Al-Chalabi A, Hardiman O, Kiernan MC, Chi&#xf2; A, Rix-Brooks B, Van Den Berg LH (2016) Amyotrophic lateral sclerosis: moving towards a new classification system. Lancet Neurol 15:1182&#x2013;11943</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)30199-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouget J, Trefouret S, Attarian S (2000) Transcranial magnetic stimulation (TMS): compared sensitivity of different motor response parameters in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 1(Suppl. 2):S45&#x2013;S49</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820052415817</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bos MAJ, Geevasinga N, Higashihara M, Menon P, Vucic S (2019) Pathophysiology and diagnosis of ALS: insights from advances in neurophysiological techniques. Int J Mol Sci 20(11):2818</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20112818</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh W, Simon NG, Grosskreutz J, Turner MR, Vucic S, Kiernan MC (2016) Assessment of the upper motor neuron in amyotrophic lateral sclerosis. Clin Neurophysiol 127:2643&#x2013;2660</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2016.04.025</ArticleId></ArticleIdList></Reference><Reference><Citation>Swash M (2012) Why are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis?: figure 1. J Neurol Neurosurg Psychiatry 83:659&#x2013;662</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-302315</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan JY, Jeong SY, Van Gelderen P et al (2012) Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One 7:e35241</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035241</ArticleId></ArticleIdList></Reference><Reference><Citation>Roeben B, Wilke C, Bender B, Ziemann U, Synofzik M (2019) The motor band sign in ALS: presentations and frequencies in a consecutive series of ALS patients. J Neurol Sci 406:116440</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.116440</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi Y, Sato N, Saito Y et al (2015) Usefulness of SWI for the detection of Iron in the motor cortex in amyotrophic lateral sclerosis. J Neuroimaging 25:443&#x2013;451</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jon.12127</ArticleId></ArticleIdList></Reference><Reference><Citation>Contarino VE, Conte G, Morelli C et al (2020) Toward a marker of upper motor neuron impairment in amyotrophic lateral sclerosis: a fully automatic investigation of the magnetic susceptibility in the precentral cortex. Eur J Radiol 124:108815. https://doi.org/10.1016/j.ejrad.2020.108815</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejrad.2020.108815</ArticleId><ArticleId IdType="pubmed">31945675</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner MR, Talbot K (2013) Mimics and chameleons in motor neurone disease. Pract Neurol 13:153&#x2013;164</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/practneurol-2013-000557</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousry TA, Schmid UD, Alkadhi H et al (1997) Localization of the motor hand area to a knob on the precentral gyrus. A new landmark. Brain 120(Pt 1):141&#x2013;157</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/120.1.141</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe1;zquez-Costa JF, Maz&#xf3;n M, Carreres-Polo J et al (2018) Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis. Acta Neurol Scand 137:262&#x2013;271</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12863</ArticleId></ArticleIdList></Reference><Reference><Citation>Oba H, Araki T, Ohtomo K et al (1993) Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 189:843&#x2013;846</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.189.3.8234713</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa K, Nagura H, Yokota T, Yamanouchi H (1993) Signal loss in the motor cortex on magnetic resonance images in amyotrophic lateral sclerosis. Ann Neurol 33:218&#x2013;222</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410330214</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheelakumari R, Madhusoodanan M, Radhakrishnan A, Ranjith G, Thomas B (2016) A potential biomarker in amyotrophic lateral sclerosis: can assessment of brain iron deposition with SWI and corticospinal tract degeneration with DTI help? AJNR Am J Neuroradiol 37:252&#x2013;258</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A4524</ArticleId></ArticleIdList></Reference><Reference><Citation>Costagli M, Donatelli G, Biagi L et al (2016) Magnetic susceptibility in the deep layers of the primary motor cortex in amyotrophic lateral sclerosis. NeuroImage Clin 12:965&#x2013;969</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.04.011</ArticleId></ArticleIdList></Reference><Reference><Citation>Schweitzer AD, Liu T, Gupta A et al (2015) Quantitative susceptibility mapping of the motor cortex in amyotrophic lateral sclerosis and primary lateral sclerosis. AJR Am J Roentgenol 204:1086&#x2013;1092</Citation><ArticleIdList><ArticleId IdType="doi">10.2214/AJR.14.13459</ArticleId></ArticleIdList></Reference><Reference><Citation>Callaghan MF, Freund P, Draganski B et al (2014) Widespread age-related differences in the human brain microstructure revealed by quantitative magnetic resonance imaging. Neurobiol Aging 35:1862&#x2013;1872</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.02.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen BC, Pattany PM, Bradley WG et al (2000) MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 21:647&#x2013;658</Citation><ArticleIdList><ArticleId IdType="pubmed">10782773</ArticleId></ArticleIdList></Reference><Reference><Citation>Golko-Perez S, Amit T, Bar-Am O et al (2017) A novel Iron Chelator-radical scavenger ameliorates motor dysfunction and improves life span and mitochondrial biogenesis in SOD1G93A ALS mice. Neurotox Res 31:230&#x2013;244</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12640-016-9677-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong SY, Rathore KI, Schulz K, Ponka P, Arosio P, David S (2009) Dysregulation of iron homeostasis in the CNS contributes to disease progression in a mouse model of amyotrophic lateral sclerosis. J Neurosci 29:610&#x2013;619</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.5443-08.2009</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreau C, Danel V, Devedjian JC et al (2018) Could conservative Iron chelation lead to neuroprotection in amyotrophic lateral sclerosis? Antioxid Redox Signal 29:742&#x2013;748</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7493</ArticleId></ArticleIdList></Reference><Reference><Citation>Park M, Moon Y, Han SH, Moon WJ (2019) Motor cortex hypointensity on susceptibility-weighted imaging: a potential imaging marker of iron accumulation in patients with cognitive impairment. Neuroradiology 61(6):675&#x2013;683. https://doi.org/10.1007/s00234-019-02159-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00234-019-02159-3</ArticleId><ArticleId IdType="pubmed">30693411</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Radaideh A, Athamneh I, Alabadi H, Hbahbih M (2019) Cortical and subcortical morphometric and iron changes in relapsing-remitting multiple sclerosis and their association with white matter T2 lesion load : a 3-tesla magnetic resonance imaging study. Clin Neuroradiol 29(1):51&#x2013;64. https://doi.org/10.1007/s00062-017-0654-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00062-017-0654-0</ArticleId><ArticleId IdType="pubmed">29299614</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri S, K&#xf6;rner S, Kiaei M (2012) Nrf2/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS. Neurol Res Int 2012:1&#x2013;7</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/878030</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosottini M, Cecchi P, Piazza S et al (2013) Mapping cortical degeneration in ALS with magnetization transfer ratio and voxel-based Morphometry. PLoS One 8:e68279</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0068279</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; MT, Ferri A, Cozzolino M, Calabrese L, Rotilio G (2003) Neurodegeneration in amyotrophic lateral sclerosis: the role of oxidative stress and altered homeostasis of metals. Brain Res Bull 61:365&#x2013;374</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0361-9230(03)00179-5</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>